We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 33

Court Orders Elimination of Medicare Appeals Backlog by 2022
  • K&L Gates
  • USA
  • November 6 2018

On November 1, 2018, the United States District Court for the District of Columbia (“District Court”) issued an order and memorandum opinion


340B update: Hospital groups file (...and refile) 340B Program litigation
  • K&L Gates
  • USA
  • September 19 2018

Regulation and reimbursement of drugs, particularly those purchased through the 340B Drug Discount Program (the "340B Program" or "340B"), continue


340B Update: D.C. Court of Appeals Upholds Medicare Part B Reimbursement Cut
  • K&L Gates
  • USA
  • July 20 2018

On July 17, 2018, the U.S. Court of Appeals for the District of Columbia rendered a decision upholding the reimbursement cut that took effect on


Increased Scrutiny of Patient Assistance Programs: Enforcement Overview and Considerations
  • K&L Gates
  • USA
  • March 20 2018

In the midst of ongoing national debates regarding drug pricing and access to innovative therapies, patient assistance programs (“PAPs”) are


Opioid Epidemic: Update on Policy Issues in Washington, DC.
  • K&L Gates
  • USA
  • February 22 2018

In the third episode of our series on the national opioid crisis, Amanda Makki and Corbin Santo provide an overview of how the Trump Administration


2017 Updates to the OIG’s Active Work Plan Items & Related Audit Experience
  • K&L Gates
  • USA
  • December 20 2017

In this episode, Hilary Bowman summarizes recent updates to the U.S. Department of Health & Human Services, Office of Inspector General (OIG) 2017


President’s Opioid Commission Issues Final Recommendations: Implications for Health Care Stakeholders
  • K&L Gates
  • USA
  • November 14 2017

In late October, President Trump declared the nation’s opioid addiction crisis a public health emergency. Less than a week later, the President’s


Trump Administration Seeks Stakeholder Input on New Direction for CMS Innovation Center
  • K&L Gates
  • USA
  • October 2 2017

On September 20, 2017, the Centers for Medicare and Medicaid Services (“CMS”) released an informal request for information (“RFI”) seeking stakeholder


K&L Gates Triage: Emerging Themes for Emergency Departments: What to Know About Treating Psychiatric Patients Under EMTALA
  • K&L Gates
  • USA
  • July 26 2017

This Episode discusses some of the emerging themes and challenges that many hospitals are facing with the increasing number of psychiatric patients


340B Update: Trump Administration Calls for New Legislation and Regulatory Authority; HRSA Delays Regulations on 340B Pricing & Penalties for Drug Manufacturers to October 1, 2017
  • K&L Gates
  • USA
  • May 30 2017

Recent developments from the Trump administration relating to the 340B Drug Pricing Program (“340B Program”) could have a significant impact on